drugset / Trial / NCT07470866

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

NCT07470866

Phase 1 Terminated 24 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this clinical trial is to compare the amount of tafamidis in the blood of healthy adult participants after taking two different forms of tafamidis by mouth under fed conditions.

Timeline

Start
2026-03-23
Primary completion
2026-05-12
Completion
2026-06-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tafamidis Unknown 61 mg Oral

Indications

No indication recorded.